Genetics of common disease and diagnostics

Common diseases occur at the interface of genes and the environment, as both inherited as well as lifestyle and other health risk factors play important roles in the disease process. A better and more personalized understanding of risk may therefore help to empower individuals and their doctors to implement more rigorous and potentially more effective prevention strategies, with the goal of reducing the likelihood that an inherited predisposition to a given condition may go on to develop into a disease.

deCODE T2™ - for gauging risk of Type 2 DiabetesdeCODE T2™ is performed in deCODE’s CLIA-registered laboratory. The test can only be ordered by qualified physicians and medical practitioners.
deCODE T2™ is a DNA-based test designed to help individuals, working with their doctor, better understand their risk of type 2 diabetes (T2D) and to enable more effective prevention strategies.
Read more >>



deCODE MI™ - for gauging risk of MI deCODE MI™ is performed in deCODE’s CLIA-registered laboratory. The test can only be ordered by qualified physicians and medical practitioners.
deCODE MI™ is a reference laboratory DNA test for assessing an inherited risk factor for myocardial infarction (MI). The test detects versions of  SNPs (single nucleotide polymorphism) – single letter variations in the sequence of the genome – in a region of the genome that deCODE has linked to increased risk of MI.
Read more >>

deCODE Glaucoma™ -
 for gauging risk of Glaucoma
deCODE Glaucoma™ is performed in deCODE’s CLIA-registered laboratory. The test can only be ordered by qualified physicians and medical practitioners.deCODE Glaucoma™ is a reference laboratory DNA test for assessing an inherited risk factor for exfoliation glaucoma. The deCODE Glaucoma™ test detects versions of SNPs (single nucleotide polymorphism) – single letter variations in the sequence of the genome – in a specific gene that deCODE has linked to increased risk of one of the more common types of glaucoma, exfoliation type glaucoma.
Read more >>

deCODE ProstateCancer™ -
 for gauging risk of Prostate Cancer
deCODE ProstateCancer™ is performed in deCODE’s CLIA-registered laboratory. The test can only be ordered by qualified physicians and medical practitioners.deCODE ProstateCancer™ is a reference laboratory DNA test for assessing an inherited risk factor for Prostate Cancer.
Read more >>

 

 

deCODE BreastCancer™ -
 for gauging risk of Breast Cancer
 deCODE BreastCancer™ is performed in deCODE’s CLIA-registered laboratory. The test can only be ordered by qualified physicians and medical practitioners. deCODE BreastCancer is a reference laboratory DNA test for assessing individual risk of the common forms of breast cancer. the common forms of the disease account for approximately 95% of all breast cancers, and the test detects versions of seven SNPs that deCODE and others have linked to risk of breast cancer in studies involving some 100,000 patients and controls from many populations.
Read more >>

 

 

About deCODE genetics
deCODE is a global leader in gene discovery - our population approach and resources have enabled us to isolate key genes contributing to major public health challenges from cardiovascular disease to cancer.
Read more >>